ABSTRACT
The aim of this work was to evaluate the mesenchymal stem cells treatment of rats with myonecrosis caused by Rhinocerophis alternatus venom through acute phase proteins (APP) profile. The animals were distributed into three experimental groups (G1, G2 and G3). G1 and G2 were inoculated with 120 μg of R. alternatus venom diluted in 200 µL of ultra-pure water in gastrocnemic muscle, while G3 received 200 µL of ultra-pure water. Three days after, G1 was treated with 5 X 10(6) MSC diluted in PBS and G2 and G3 only with PBS. Each three days after the treatments (3rd, 6th, 9th, 12th 15th days), blood of five animals in each group was collected in order to evaluate the APP. A decrease (P<0.05) in α2-globulin fraction was observed in G1 on the 6th day. In G1 and G2, a raise (P<0.05) was observed in β globulin, a common occurrence in the late phases of inflammatory process, although no significant difference was observed between them. Concerning gamma globulins levels, on the 6th day after the treatments, in G1 and G2 groups, increase in the levels was observed. These data showed that the MSC treatment after bothropic envenomation in the rats caused alteration in APP.
ABSTRACT
A doença causada pelo rotavírus é responsável por elevada taxa de hospitalização e de mortes em crianças. O desenvolvimento de vacina eficaz contra o vírus assumiu caráter prioritário para organismos como a Organização Mundial de Saúde (OMS). A intussuscepção intestinal, entretanto, representa manifestações relacionadas ao uso da vacina que ainda constitui preocupação quanto ao seu uso disseminado. No Brasil, encontram-se disponíveis as vacinas do tipo RV1 e RV5, não sendo observado aumento de risco significativo de intussuscepção nas crianças com menos de sete dias de vida. Os benefícios que as vacinações trouxeram, pelas reduções de hospitalizações e mortalidade infantil no mundo, continuam a indicar a sua vacinação. (AU)
The overall impact of the disease caused by rotavirus is still a major cause of hospitalizations and deaths in children. The development of an effective vaccine against the virus became a priority for organizations like WHO (World Health Organization). Intestinal intussusception is one manifestation of which was related to vaccine use. In Brazil, are available vaccines RV1and RV5 type, and there was no significant increase in the risk of intussusception in children less than seven days. The benefits brought vaccinations, by reductions in hospitalizations and mortality in the world, continue to indicate the worldwide vaccination against rotavirus by WHO. (AU)